{
  "DOI": "10.1007/s10689-007-9147-7",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-007-9147-7",
  "alternative-id": [
    "9147"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Rubinstein",
      "given": "Wendy S.",
      "sequence": "first"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2007,
        7,
        16
      ]
    ],
    "date-time": "2007-07-16T23:13:03Z",
    "timestamp": 1184627583000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:45:56Z",
    "timestamp": 1559252756000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ],
    "date-time": "2023-10-03T00:03:41Z",
    "timestamp": 1696291421256
  },
  "is-referenced-by-count": 26,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2007,
        7,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2008,
          3
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2007,
            7,
            12
          ]
        ],
        "date-time": "2007-07-12T00:00:00Z",
        "timestamp": 1184198400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-007-9147-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-007-9147-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-007-9147-7",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "83-89",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2007,
        7,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2007,
        7,
        12
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2008,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s10689-005-2832-5",
      "author": "WD Foulkes",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "9147_CR1",
      "unstructured": "Foulkes WD (2006) BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis. Fam Cancer 5(2):135–142",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S0140-6736(96)10109-4",
      "doi-asserted-by": "crossref",
      "key": "9147_CR2",
      "unstructured": "Anonymous, Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 1997;349(9064):1505–1510"
    },
    {
      "DOI": "10.1093/jnci/90.15.1138",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "1138",
      "issue": "15",
      "journal-title": "J Natl Cancer Inst",
      "key": "9147_CR3",
      "unstructured": "Lakhani SR, Jacquemier J, Sloane JP et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90(15):1138–1145",
      "volume": "90",
      "year": "1998"
    },
    {
      "DOI": "10.1200/JCO.2002.09.023",
      "doi-asserted-by": "crossref",
      "key": "9147_CR4",
      "unstructured": "Lakhani SR, Van de Vijver MJ, V, Jacquemier J et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310–2318"
    },
    {
      "DOI": "10.1200/JCO.2000.18.24.4045",
      "author": "PO Chappuis",
      "doi-asserted-by": "crossref",
      "first-page": "4045",
      "issue": "24",
      "journal-title": "J Clin Oncol",
      "key": "9147_CR5",
      "unstructured": "Chappuis PO, Kapusta L, Begin LR et al (2000) Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer. J Clin Oncol 18(24):4045–4052",
      "volume": "18",
      "year": "2000"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-2424",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "5175",
      "issue": "14",
      "journal-title": "Clin Cancer Res",
      "key": "9147_CR6",
      "unstructured": "Lakhani SR, Reis-Filho JS, Fulford L et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11(14):5175–5180",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1155/1999/459486",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "113",
      "issue": "1–3",
      "journal-title": "Dis Markers",
      "key": "9147_CR7",
      "unstructured": "Lakhani SR (1999) The pathology of hereditary breast cancer. Dis Markers 15(1–3):113–114",
      "volume": "15",
      "year": "1999"
    },
    {
      "DOI": "10.1200/JCO.2005.01.3698",
      "author": "E Honrado",
      "doi-asserted-by": "crossref",
      "first-page": "7503",
      "issue": "30",
      "journal-title": "J Clin Oncol",
      "key": "9147_CR8",
      "unstructured": "Honrado E, Osorio A, Palacios J et al (2005) Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors. J Clin Oncol 23(30):7503–7511",
      "volume": "23",
      "year": "2005"
    },
    {
      "author": "MS Greenblatt",
      "first-page": "4092",
      "issue": "10",
      "journal-title": "Cancer Res",
      "key": "9147_CR9",
      "unstructured": "Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD (2001) TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res 61(10):4092–4097",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1038/415530a",
      "author": "LJ ‘t Veer",
      "doi-asserted-by": "crossref",
      "first-page": "530",
      "issue": "6871",
      "journal-title": "Nature",
      "key": "9147_CR10",
      "unstructured": "‘t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530–536",
      "volume": "415",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJMoa041588",
      "author": "S Paik",
      "doi-asserted-by": "crossref",
      "first-page": "2817",
      "issue": "27",
      "journal-title": "N Engl J Med",
      "key": "9147_CR11",
      "unstructured": "Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817–2826",
      "volume": "351",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-1707",
      "author": "FJ Esteva",
      "doi-asserted-by": "crossref",
      "first-page": "3315",
      "issue": "9",
      "journal-title": "Clin Cancer Res",
      "key": "9147_CR12",
      "unstructured": "Esteva FJ, Sahin AA, Cristofanilli M et al (2005) Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Clin Cancer Res 11(9):3315–3319",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1093/jnci/96.9.648",
      "author": "RS Tuma",
      "doi-asserted-by": "crossref",
      "first-page": "648",
      "issue": "9",
      "journal-title": "J Natl Cancer Inst",
      "key": "9147_CR13",
      "unstructured": "Tuma RS (2004) A big trial for a new technology: TransBIG Project takes microarrays into clinical trials. J Natl Cancer Inst 96(9):648–649",
      "volume": "96",
      "year": "2004"
    },
    {
      "DOI": "10.1038/ncponc0591",
      "author": "J Bogaerts",
      "doi-asserted-by": "crossref",
      "first-page": "540",
      "issue": "10",
      "journal-title": "Nat Clin Pract Oncol",
      "key": "9147_CR14",
      "unstructured": "Bogaerts J, Cardoso F, Buyse M et al (2006) Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. Nat Clin Pract Oncol 3(10):540–551",
      "volume": "3",
      "year": "2006"
    },
    {
      "DOI": "10.1038/35021093",
      "author": "CM Perou",
      "doi-asserted-by": "crossref",
      "first-page": "747",
      "issue": "6797",
      "journal-title": "Nature",
      "key": "9147_CR15",
      "unstructured": "Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747–752",
      "volume": "406",
      "year": "2000"
    },
    {
      "DOI": "10.1073/pnas.0932692100",
      "author": "T Sorlie",
      "doi-asserted-by": "crossref",
      "first-page": "8418",
      "issue": "14",
      "journal-title": "PNAS",
      "key": "9147_CR16",
      "unstructured": "Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. PNAS 100(14):8418–8423",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1073/pnas.97.17.9603",
      "author": "T Kainu",
      "doi-asserted-by": "crossref",
      "first-page": "9603",
      "issue": "17",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9147_CR17",
      "unstructured": "Kainu T, Juo SH, Desper R et al (2000) Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci USA 97(17):9603–9608",
      "volume": "97",
      "year": "2000"
    },
    {
      "author": "LF Wessels",
      "first-page": "7110",
      "issue": "23",
      "journal-title": "Cancer Res",
      "key": "9147_CR18",
      "unstructured": "Wessels LF, van Welsem T, Hart AA, Van’t Veer LJ, Reinders MJ, Nederlof PM (2002) Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. Cancer Res 62(23):7110–7117",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-05-0570",
      "author": "G Jonsson",
      "doi-asserted-by": "crossref",
      "first-page": "7612",
      "issue": "17",
      "journal-title": "Cancer Res",
      "key": "9147_CR19",
      "unstructured": "Jonsson G, Naylor TL, Vallon-Christersson J et al (2005) Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res 65(17):7612–7621",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJM200102223440801",
      "author": "I Hedenfalk",
      "doi-asserted-by": "crossref",
      "first-page": "539",
      "issue": "8",
      "journal-title": "N Engl J Med",
      "key": "9147_CR20",
      "unstructured": "Hedenfalk I, Duggan D, Chen Y et al (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344(8):539–548",
      "volume": "344",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0011-3840(01)70035-4",
      "author": "ME Robson",
      "doi-asserted-by": "crossref",
      "first-page": "387",
      "issue": "6",
      "journal-title": "Curr Probl Surg",
      "key": "9147_CR21",
      "unstructured": "Robson ME, Boyd J, Borgen PI, Cody HS III (2001) Hereditary breast cancer. Curr Probl Surg 38(6):387–480",
      "volume": "38",
      "year": "2001"
    },
    {
      "DOI": "10.1186/bcr658",
      "author": "ME Robson",
      "doi-asserted-by": "crossref",
      "first-page": "R8",
      "issue": "1",
      "journal-title": "Breast Cancer Res",
      "key": "9147_CR22",
      "unstructured": "Robson ME, Chappuis PO, Satagopan J et al (2004) A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 6(1):R8-R17",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1186/bcr748",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "E7",
      "issue": "1",
      "journal-title": "Breast Cancer Res",
      "key": "9147_CR23",
      "unstructured": "Evans DG, Howell A (2004) Are BRCA1- and BRCA2-related breast cancers associated with increased mortality? Breast Cancer Res 6(1):E7",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1002/cncr.11688",
      "author": "WD Foulkes",
      "doi-asserted-by": "crossref",
      "first-page": "1569",
      "issue": "8",
      "journal-title": "Cancer",
      "key": "9147_CR24",
      "unstructured": "Foulkes WD, Metcalfe K, Hanna W et al (2003) Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer 98(8):1569–1577",
      "volume": "98",
      "year": "2003"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-03-2970",
      "author": "WD Foulkes",
      "doi-asserted-by": "crossref",
      "first-page": "830",
      "issue": "3",
      "journal-title": "Cancer Res",
      "key": "9147_CR25",
      "unstructured": "Foulkes WD, Brunet JS, Stefansson IM et al (2004) The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res 64(3):830–835",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmg.39.8.608",
      "author": "PO Chappuis",
      "doi-asserted-by": "crossref",
      "first-page": "608",
      "issue": "8",
      "journal-title": "J Med Genet",
      "key": "9147_CR26",
      "unstructured": "Chappuis PO, Goffin J, Wong N et al (2002) A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer. J Med Genet 39(8):608–610",
      "volume": "39",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/90.18.1371",
      "author": "B Fisher",
      "doi-asserted-by": "crossref",
      "first-page": "1371",
      "issue": "18",
      "journal-title": "J Natl Cancer Inst",
      "key": "9147_CR27",
      "unstructured": "Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371–1388",
      "volume": "90",
      "year": "1998"
    },
    {
      "DOI": "10.1001/jama.295.23.joc60074",
      "author": "VG Vogel",
      "doi-asserted-by": "crossref",
      "first-page": "2727",
      "issue": "23",
      "journal-title": "JAMA",
      "key": "9147_CR28",
      "unstructured": "Vogel VG, Costantino JP, Wickerham DL et al (2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295(23):2727–2741",
      "volume": "295",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.bjc.6600064",
      "author": "SW Duffy",
      "doi-asserted-by": "crossref",
      "first-page": "218",
      "issue": "2",
      "journal-title": "Br J Cancer",
      "key": "9147_CR29",
      "unstructured": "Duffy SW, Nixon RM (2002) Estimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutations. Br J Cancer 86(2):218–221",
      "volume": "86",
      "year": "2002"
    },
    {
      "DOI": "10.1038/sj.bjc.6603042",
      "author": "M Bramley",
      "doi-asserted-by": "crossref",
      "first-page": "1021",
      "issue": "7",
      "journal-title": "Br J Cancer",
      "key": "9147_CR30",
      "unstructured": "Bramley M, Clarke RB, Howell A et al (2006) Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations. Br J Cancer 94(7):1021–1028",
      "volume": "94",
      "year": "2006"
    },
    {
      "DOI": "10.1093/jnci/94.19.1504-a",
      "author": "WD Foulkes",
      "doi-asserted-by": "crossref",
      "first-page": "1504",
      "issue": "19",
      "journal-title": "J Natl Cancer Inst",
      "key": "9147_CR31",
      "unstructured": "Foulkes WD, Goffin J, Brunet JS, Begin LR, Wong N, Chappuis PO (2002) Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor status. J Natl Cancer Inst 94(19):1504–1506",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1210/en.2004-0409",
      "author": "J Xu",
      "doi-asserted-by": "crossref",
      "first-page": "2031",
      "issue": "4",
      "journal-title": "Endocrinology",
      "key": "9147_CR32",
      "unstructured": "Xu J, Fan S, Rosen EM (2005) Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1. Endocrinology 146(4):2031–2047",
      "volume": "146",
      "year": "2005"
    },
    {
      "DOI": "10.1001/jama.286.18.2251",
      "author": "MC King",
      "doi-asserted-by": "crossref",
      "first-page": "2251",
      "issue": "18",
      "journal-title": "JAMA",
      "key": "9147_CR33",
      "unstructured": "King MC, Wieand S, Hale K et al (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 286(18):2251–2256",
      "volume": "286",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0140-6736(00)03258-X",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "1876",
      "issue": "9245",
      "journal-title": "Lancet",
      "key": "9147_CR34",
      "unstructured": "Narod SA, Brunet JS, Ghadirian P et al (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 356(9245):1876–1881",
      "volume": "356",
      "year": "2000"
    },
    {
      "DOI": "10.1002/ijc.21536",
      "author": "J Gronwald",
      "doi-asserted-by": "crossref",
      "first-page": "2281",
      "issue": "9",
      "journal-title": "Int J Cancer",
      "key": "9147_CR35",
      "unstructured": "Gronwald J, Tung N, Foulkes WD et al (2006) Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118(9):2281–2284",
      "volume": "118",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2003.02.107",
      "author": "BN Peshkin",
      "doi-asserted-by": "crossref",
      "first-page": "4322",
      "issue": "23",
      "journal-title": "J Clin Oncol",
      "key": "9147_CR36",
      "unstructured": "Peshkin BN, Isaacs C, Finch C, Kent S, Schwartz MD (2003) Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians. J Clin Oncol 21(23):4322–4328",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/djh097",
      "author": "SM Swain",
      "doi-asserted-by": "crossref",
      "first-page": "516",
      "issue": "7",
      "journal-title": "J Natl Cancer Inst",
      "key": "9147_CR37",
      "unstructured": "Swain SM, Wilson JW, Mamounas EP et al (2004) Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer. J Natl Cancer Inst 96(7):516–523",
      "volume": "96",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10689-005-4215-3",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "9147_CR38",
      "unstructured": "Metcalfe KA, Snyder C, Seidel J, Hanna D, Lynch HT, Narod S (2005) The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. Fam Cancer 4(2):97–103",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.1101/sqb.2005.70.012",
      "author": "AN Tutt",
      "doi-asserted-by": "crossref",
      "first-page": "139",
      "journal-title": "Cold Spring Harb Symp Quant Biol",
      "key": "9147_CR39",
      "unstructured": "Tutt AN, Lord CJ, McCabe N et al (2005) Exploiting the DNA repair defect in BRCA mutant cells in the design of new therapeutic strategies for cancer. Cold Spring Harb Symp Quant Biol 70:139–148",
      "volume": "70",
      "year": "2005"
    },
    {
      "key": "9147_CR40",
      "unstructured": "Ref Type: Internet Communication, 3-2-2007"
    },
    {
      "DOI": "10.1038/nature03445",
      "author": "H Farmer",
      "doi-asserted-by": "crossref",
      "first-page": "917",
      "issue": "7035",
      "journal-title": "Nature",
      "key": "9147_CR41",
      "unstructured": "Farmer H, McCabe N, Lord CJ et al (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434(7035):917–921",
      "volume": "434",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nature03443",
      "author": "HE Bryant",
      "doi-asserted-by": "crossref",
      "first-page": "913",
      "issue": "7035",
      "journal-title": "Nature",
      "key": "9147_CR42",
      "unstructured": "Bryant HE, Schultz N, Thomas HD et al (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434(7035):913–917",
      "volume": "434",
      "year": "2005"
    },
    {
      "DOI": "10.4161/cc.4.9.2031",
      "author": "T Helleday",
      "doi-asserted-by": "crossref",
      "first-page": "1176",
      "issue": "9",
      "journal-title": "Cell Cycle",
      "key": "9147_CR43",
      "unstructured": "Helleday T, Bryant HE, Schultz N (2005) Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy. Cell Cycle 4(9):1176–1178",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nrd1718",
      "author": "P Jagtap",
      "doi-asserted-by": "crossref",
      "first-page": "421",
      "issue": "5",
      "journal-title": "Nat Rev Drug Discov",
      "key": "9147_CR44",
      "unstructured": "Jagtap P, Szabo C (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4(5):421–440",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.1073/pnas.0600554103",
      "author": "CC Alano",
      "doi-asserted-by": "crossref",
      "first-page": "9685",
      "issue": "25",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9147_CR45",
      "unstructured": "Alano CC, Kauppinen TM, Valls AV, Swanson RA (2006) Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci USA 103(25):9685–9690",
      "volume": "103",
      "year": "2006"
    }
  ],
  "reference-count": 45,
  "references-count": 45,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-007-9147-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics"
  ],
  "type": "journal-article",
  "volume": "7"
}